Taro Pharmaceutical EPS misses by $0.11, beats on revenue

• Taro Pharmaceutical (NYSE:TARO): Q1 Non-GAAP EPS of $0.81 misses by $0.11; GAAP EPS of -$0.78 misses by $1.70.
• Revenue of $148.35M (-15.2% Y/Y) beats by $1.02M.
• Press Release